scispace - formally typeset
N

Nader Pouratian

Researcher at University of California, Los Angeles

Publications -  282
Citations -  8128

Nader Pouratian is an academic researcher from University of California, Los Angeles. The author has contributed to research in topics: Deep brain stimulation & Medicine. The author has an hindex of 46, co-authored 240 publications receiving 6790 citations. Previous affiliations of Nader Pouratian include University of California & University of California, Berkeley.

Papers
More filters
Journal ArticleDOI

Linear and Nonlinear Relationships between Neuronal Activity, Oxygen Metabolism, and Hemodynamic Responses

TL;DR: The results indicate that caution is required in the interpretation of perfusion-based indicators of brain activity, such as functional magnetic resonance imaging (fMRI), and may help to refine quantitative models of neurovascular coupling.
Journal ArticleDOI

Gamma Knife surgery for Cushing's disease.

TL;DR: In this article, the efficacy and safety of Gamma Knife surgery (GKS) in patients with adrenocorticotropic hormone-secreting pituitary adenomas was addressed, and the successful endocrine outcome after GKS was defined as a normal 24-hour urinary free cortisol (UFC) concentration after a minimum of 1 year of follow up.
Journal ArticleDOI

Incidence of symptomatic hemorrhage after stereotactic electrode placement

TL;DR: Hypertension is a significant risk factor for hemorrhage in patients with various diseases treated with stereotactic electrode placement, and the effect of comorbidities on the risk of ICH is evaluated.
Journal ArticleDOI

Impact of the Accreditation Council for Graduate Medical Education work-hour regulations on neurosurgical resident education and productivity.

TL;DR: An analysis of the UVA experience suggested that the 80-hour workweek leads to a notable increase in on-call duty hours with a profound decrease in the number of hours spent in conference and the operating room.
Journal ArticleDOI

Gamma Knife surgery for pituitary adenomas: factors related to radiological and endocrine outcomes

TL;DR: Smaller adenoma volume improves the probability of endocrine remission and lowers the risk of new pituitary hormone deficiency with GKS, and a higher margin dose offers a greater chance of endocrin remission and control of tumor growth.